| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9385936 | Respiratory Medicine | 2005 | 7 Pages |
Abstract
Conclusions: Serum YKL-40 may be a novel biomarker of sarcoid disease activity and ongoing fibrosis in patients with pulmonary sarcoidosis.
Related Topics
Health Sciences
Medicine and Dentistry
Pulmonary and Respiratory Medicine
Authors
Julia S. Johansen, Nils Milman, Michael Hansen, Charly Garbarsch, Paul A. Price, Niels Graudal,